1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 30 NOVEMBER 2015

Cancer Drug News 30 NOVEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Early Adoption Of Open Innovation To Set Companies Apart
Industry Brief - Sunesis Granted European Patent Covering Qinprezo
Industry Brief - CHMP Recommends Oncaspar For ALL In Combination Therapy
Industry Brief - EC Conditionally Approves Blincyto For Ph- ALL
Industry Brief - CTI Initiates Rolling NDA Submission For Pacritinib In MF
Industry Brief - EC Approves Expanded Label For Xalkori
Industry Brief - Aduro's CRS-207 Gains EU Orphan Designation For MPM
Industry Brief - First Patient Dosed In Tipifarnib Phase II Trial
Industry Trend Analysis - Vaccine Rollout Programmes Will Prove To Be Challenging
Industry Brief - Elplat Indication Expanded In Japan
Industry Brief - XBiotech Reveals Xilonix Phase III CRC Trial Irregularities
Industry Brief - EC Approves Cotellic/Zelboraf Combination For Advanced Melanoma
Industry Trend Analysis - Aduro Entering A Defining Period
Industry Brief - Cellceutix' Kevetrin Gains FDA ODD For Retinoblastoma
Industry Brief - Opdivo Expands Indications In US/Aligns EU Brandname
Industry Trend Analysis - SSA Cancer Burden Driving Diagnostic Demand

Table Of Contents

Cancer Drug News 30 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


Download Unlimited Documents from Trusted Public Sources

Hormone and Therapy Market in Pakistan and the US

  • January 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Cancer Statistics in the US

  • January 2017
    29 pages
  • Cancer  

    Oncology  

    Infectious Dise...  

  • United States  

View report >

Antidiabetics Market in Sweden

  • January 2017
    8 pages
  • Antidiabetics  

    Prostate Cancer  

    Type 2 Diabetes  

  • Sweden  

View report >

Therapy Market

1 day ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.